DepoMed, Inc. (NASDAQ:DEPO)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Recs

0
Player Avatar eesirrius (< 20) Submitted: 7/15/2011 10:18:11 AM : Outperform Start Price: $8.39 DEPO Score: -35.46

MFI Screen

Featured Broker Partners


Advertisement